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Aggregatibacter actinomycetemcomitansStreblus asper leaf extract (SAE) possesses antibacterial activity towards Streptococcus mutans and periodontal
pathogens, such as Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. However, there is no
report on inhibitory effects of SAE against subgingival bioﬁlm formation. The purpose of this study was to
investigate the inhibitory effects of SAE on subgingival bioﬁlm formation using an in vitro model. Subgingival
plaque samples from 5 periodontitis patients were cultivated in saliva-coated 96-well microtiter plates in the
presence of SAE at concentrations 0.5–90 mg/ml under anaerobic atmosphere at 37 °C for 2, 4 and 8 days by
replacing every 2 days with fresh medium alone or SAE-containing medium. Bioﬁlm formation was determined
quantitatively by crystal violet staining. TaqMan-based real-time polymerase chain reactionwas used to quantify
the numbers of P. gingivalis, A. actinomycetemcomitans and total bacteria in the grown subgingival bioﬁlm.
The results showed that SAE exhibited more than 70% anti-bioﬁlm activity at 90 mg/ml. The reduction in cell
numbers of P. gingivalis, A. actinomycetemcomitans and total bacteria in subgingival bioﬁlm of test groups were
observed compared to untreated control. These results revealed that SAE is able to inhibit in vitro subgingival
bioﬁlm formation and reduce the numbers of P. gingivalis, A. actinomycetemcomitans and total bacteria.
© 2014 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
The oral cavity is an ideal environment for bioﬁlm development.
Most common infections of the oral cavity, e.g. caries, gingivitis and
periodontitis result from the accumulation of bioﬁlms. Bacteria that
are sessile (attached to a surface) express different genes and, so,
behave differently from free-ﬂoating or planktonic bacteria. Notable
among these differences is up to a 1000-fold increase in resistance to
antimicrobial agents for a species in a mature bioﬁlm relative to that
same species grown planktonically (Gilbert et al., 1997).
Medicinal plants as new sources of antimicrobial agents have
attracted considerable research interest. Awide variety of plant extracts
has been reported to have antimicrobial effects and anti-inﬂammatory
properties and, in fact, several herbal extracts have been added to
some cosmetics and healthcare preparations (Aburjai and Natsheh,
2003; Uprety et al., 2012; Fatima et al., 2013; Hassan-Abdallah et al.,
2013). Streblus asper Lour, Moraceae, is a medicinal plant which has
been used as a remedy for relief of fever, dysentery and toothache,
and as an antigingivitis agent (Gaitonde et al., 1964; Rastogi et al.,
2006). In the Indian traditional systemofmedicine, S. asper is prescribedosis, Faculty of Dentistry, Khon
3202 862.
apong).
hts reserved.for the treatment of diabetes mellitus. Recently, α-amyrin acetate iso-
lated from S. asper, and the petroleum ether extract of S. asper stem
bark were reported to have antidiabetic activity in streptozotocin-
induced diabetic rats (Karan et al., 2013). Anti-hepatitis B virus constit-
uents from S. asperwere also demonstrated (J. Li et al., 2012; L. Li et al.,
2012; Li et al., 2013). In addition, S. asper has been used as an antiseptic
and astringent (Mukherjee and Roy, 1983; Rastogi et al., 2006). Our
previous studies reported the antibacterial action of Streblus asper
leaf extract (SAE) against Streptococcus mutans both in vitro and
in vivo (Taweechaisupapong et al., 2000b; Wongkham et al., 2001).
We also found that SAE possesses antibacterial activity against end-
odontic and periodontal pathogens, e.g., Porphyromonas gingivalis,
Prevotella intermedia, Actinomyces naeslundii, and Aggregatibacter
actinomycetemcomitans (Taweechaisupapong et al., 2000a, 2002a).
Moreover, rinsing with SAE mouthrinse and subgingival irrigation
with SAE solution as an adjunct to scaling and root planning also have
a clinically measurable effect on gingival health (Taweechaisupapong
et al., 2002b, 2006a). Although SAE at concentration ≤250 mg/ml has
no fungicidal activity towards Candida albicans, the sublethal concentra-
tions of SAE can block the adherence of Candida to human buccal
epithelial cells and denture acrylic in vitro (Taweechaisupapong et al.,
2005, 2006b). In order to provide more information about SAE for its
potential development as a new potential therapeutic agent which
may help in the treatment of periodontitis, we evaluated the inhibitory
Table 1
Real-time PCR primers and probes used in this study.
Primers and Probes Product
size (bp)
Reference
P. gingivalis
Forward 5′-CCTACGTGTACGGACAGAGCTATA-3′ 71 Morillo et al.
(2004)Reverse 5′-AGGATCGCTCAGCGTAGCATT-3′
Probe 5′-FAM-TCGCCCGGGAAGAACTTGTCTTCA-NFQ-3′
A. actinomycetemcomitans
Forward 5′-ACGCAGACGATTGACTGAATTTAA-3′ 77 Morillo et al.
(2004)Reverse 5′-GATCTTCACAGCTATATGGCAGCTA-3′
Probe 5′-FAM-TCACCCTTCTACCGTTGCC-NFQ-3′
Total bacteria
Forward 5′-TCCTACGGGAGGCAGCAGT-3′ 466 Nadkarni
et al.
(2002)
Reverse 5′-GGACTACCAGGGTATCTAATCCTGTT-3′
Probe 5′-FAM-CGTATTACCGCGGCTGCTGGCAC-TAMRA-3′
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model.
2. Materials and methods
2.1. Preparation of Streblus asper leaf-extract
Leaves of S. asper were locally collected in Khon Kaen province and
identiﬁed by Prof. Dr. Pranom Chantaranothai, Department of Biology,
Faculty of Science, Khon Kaen University, Thailand (Berg et al., 2011).
The voucher specimens (4883; Sopit Wongkham) were deposited at
the KKU herbarium, Thailand. The leaves (1500 g) were washed, air-
dried, pulverized and soaked in 7500ml of 50% (v:v) redistilled ethanol
for 7 dayswith occasional stirring. After passing though several layers of
cheesecloth, the ethanol in the extract was evaporated under reduced
pressure at 60 °C. The remaining material was freeze-dried and kept
in a desiccator at room temperature until used. (Taweechaisupapong
et al., 2000b). Approximately 5 g of dark brown sticky extract was
obtained from 100 g of dried–pulverized leaves. The extract was
dissolved in distilled water to a ﬁnal concentration of 500 mg/ml,
centrifuged at 10,000 rpm (9410 ×g) at 4 °C for 20 min, then passed
through a 0.2 μm ﬁlter (Acrodisc® PF, Gelman Sciences, USA). The
ﬁltrate was used as the starting material for subsequent studies.
2.2. Subjects and sampling of subgingival plaque
Subjects were a convenient sample of apparently healthy Thai adults
who sought periodontal treatment at the Faculty of Dentistry, Khon
Kaen University, Khon Kaen, Thailand. The criteria used for selection in-
cluded: subjects between the ages of 35 and 45 years with no known
systemic diseases, who had not received antibiotics within the previous
3 months, and who were not taking medications that might inﬂuence
the subgingival microbiota. The study protocol was approved by the
Khon Kaen University ethical review committee. Informed consent
was obtained from all volunteers. Then subgingival plaque samples
were collected from ﬁve individuals with adult periodontitis. The
sampling site had pocket probing depths ranging from 4 to 5 mm and
clinical attachment loss ≥3 mm. The subgingival plaque was collected
by inserting a sterile absorbent paper point to the sulcus depth and
moving it laterally along the tooth surface and the sulcular epithelial
lining. The paper point sample was immediately placed into 1-ml
thioglycollate medium and gently sonicated to disperse the bacterial
cells.
2.3. Saliva collection and processing
Unstimulated saliva was obtained in 5-ml samples from the same
subjects who had donated subgingival plaque and processed as previ-
ously described (Walker and Sedlacek, 2007). In brief, each saliva sam-
plewas diluted (1:10)with pre-reduced, anaerobically-sterilized Ringer
solution, containing 0.05% cysteine (SigmaChemical Co, St Louis,MO) as
a reducing agent, and centrifuged at 2000 ×g for 10 min to remove any
particulate matter. The supernatant was passed through 0.45 μm sterile
syringe ﬁlter.
2.4. Inhibitory effects of Streblus asper leaf extract on subgingival
bioﬁlm formation
To determine the effects of SAE in inhibition of bioﬁlm formation in
test groups, subgingival plaque sample from each periodontitis patient
was cultivated in saliva-coated 96-well microtiter plate in the presence
of SAE at concentrations 0.5–90 mg/ml under anaerobic atmosphere at
37 °C for 2, 4, and 8 days (Sedlacek and Walker, 2007). A bacterial
suspension in the wells that contained only medium without SAE
served as a control group. The initial count of total bacteria, which
were inserted into each well, was 1 × 106 CFU/ml. For model 1, thesupernatant was removed at 48-h intervals and the wells were added
with fresh medium without SAE. For model 2, the supernatant was
removed and the wells were added with medium containing 0.5–
90 mg/ml SAE at 48-h intervals. At the indicated times (2, 4, and
8 days), the supernatant in each well was removed and the wells
were washed with 200 μl of sterile phosphate buffered saline. The at-
tached bacteria were stained for 15 min with 150 μl of 1% crystal violet.
Excess stain was removed with running tap water. The plates were air
dried and the dye bound to the adherent cells was solubilized with
150 μl of 33% (v/v) glacial acetic acid per well. After transferring the
dye solution to a new plate, the optical density (OD) of each well was
measured at 595 nm using microplate reader (Varioskan Flash, Thermo
Fisher Scientiﬁc Inc., USA). Percentage of bioﬁlm formation inhibition
of SAE was calculated using the formula [1 − (OD595 sample / OD595
control)] × 100%. Concentrations of SAE exhibiting 50% inhibition
(IC50) of subgingival bioﬁlm formation in eachmodel were determined.
All experiments were repeated on three separate occasions, with tripli-
cate determinations in each experiment.
2.5. DNA extraction
The bacterial DNAs from bioﬁlm in 96-well microtiter plate were
extracted by using InstaGene Matrix (Bio-Rad Lab., CA, USA) according
to themanufacturer's instructions. Dilutions of known amounts of refer-
ence strains DNA (10–108 cells) were used to determine the standard
curve for real-time quantiﬁcation.
2.6. Real-time PCR
Primers and probes used in this study are shown in Table 1. TaqMan
probes were labeled with the reporter dye 6-carboxyﬂuorescein (FAM)
at the 5′ end and with non-ﬂuorescent quencher (NFQ) at the 3′ end.
Ampliﬁcation and detection of bacterial DNA by real-time PCR were
performed using Applied Biosystem 7500 Fast Instrument (Applied
Biosystems, USA). Samples were assayed in a 20 μl reaction mixture
containing 2 μl of template DNA, 10 μl of 2× TaqMan® Universal PCR
Master Mix (Applied Biosystem), 1 μl of 20× assay mix containing
probe, forward and reverse primers (Applied Biosystem). The cycling
conditions used were as follows: 50 °C for 2 min, 95 °C for 10 min
followed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min each. All
data were analyzed using the Applied Biosystem 7500 Fast software.
To determine the validity of using the universal probe and primers
set to estimate the total number of bacteria in a mixed culture, three
bacteria, P. gingivalis, A. actinomycetemcomitans and S. mutans, were
grown separately in vitro and equal volumes of the three cultures
mixed together. The number of P. gingivalis, A. actinomycetemcomitans
Table 2
Concentrations of Streblus asper leaf extract exhibiting 50% inhibition (IC50) of subgingival
bioﬁlm formation in each model.
Day 2 4 Model 1 4 Model 2 8 Model 1 8 Model 2
IC50 (mg/ml) 8.4 30.3 33.4 34.3 31.9
95% Conﬁdence
intervals
7.2–9.8 17.5–52.5 22.1–50.4 24.5–50.0 5.5–186.1
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and compared with the relative bacterial load determined by real-
time PCR using the universal probe and primers set (Nadkarni et al.,
2002).
2.7. Statistical analyses
Kruskal–Willis analysis and Dunn's multiple comparison tests were
carried out for comparison of bioﬁlm formation and bacterial number
between the test and control groups in both models. P values b0.05
were considered statistically signiﬁcant.
3. Results
The results showed that SAE exhibited more than 70% anti-bioﬁlm
activity at concentration 90 mg/ml on days 2, 4, and 8 of both models
(Fig. 1). The 50% inhibition concentrations (IC50) of SAE in each model
were showed in Table 2. It was clear that older bioﬁlm showed less
susceptible to SAE. However, SAE at concentration 90 mg/ml was able
to kill all A. actinomycetemcomitans in subgingival bioﬁlm on day 2, 4,
and 8 of both models (Fig. 2B), while the bactericidal activity of SAE
against P. gingivalis in subgingival bioﬁlm was observed on day 4 of
model 2 and day 8 of both models (Fig. 2A). On day 2 and day 4 of
model 1, although lower numbers of P. gingivalis in subgingival bioﬁlm
of test groups were found, they were not signiﬁcantly different com-
pared with those of untreated control (Fig. 2A). In addition, total bacte-
rial numbers in subgingival bioﬁlm of test groups were not signiﬁcantly
different compared with those of untreated control in both models
(Fig. 2C).
4. Discussion
The subgingival bioﬁlm model used in this study as described by
Walker and Sedlacek was an in vitromulti-species bioﬁlm that closely
mimics the composition of the in vivo state (Walker and Sedlacek,
2007). Therefore, this model was useful for investigating the effect ofFig. 1. Effects of different concentrations of Streblus asper leaf extract (SAE) on bioﬁlm formatio
sample / OD595 control)] × 100%. Results are from 5 periodontitis patients (N= 5). The upper a
izontal line inside each box indicates the median (50th percentile).antimicrobial agents against bioﬁlm-grown bacteria. It is well accepted
that bacteria growing in a bioﬁlm are more recalcitrant to the action of
antibiotics than cells growing in a planktonic state (Hoiby et al., 2010).
From our previous studies, we found that SAE possessed antibacterial
activity towards periodontal pathogens growing in a planktonic state
(Taweechaisupapong et al., 2002a). In addition,mouthrinses containing
SAE or subgingival irrigation with SAE solution as an adjunct to scaling
and root planning also have a clinically measurable effect on gingival
health (Taweechaisupapong et al., 2002b, 2006a).
In the present study, we further investigated the effects of SAE on
bioﬁlm formation and bioﬁlm-grown bacteria. Our data demonstrated
that SAE possessed in vitro activity in inhibiting bioﬁlm formation.
Although adherent populations were not completely eradicated by
treatment with SAE, a N70% reduction in bioﬁlm formation was detect-
ed at SAE concentration 90 mg/ml (Fig. 1). It has been also demonstrat-
ed that SAEwas able to reduce the number of A. actinomycetemcomitans
and P. gingivalis in an in vitro subgingival bioﬁlm model. These
results support the antimicrobial properties of SAE against
A. actinomycetemcomitans and P. gingivalis that were reported from
our previous study (Taweechaisupapong et al., 2002a). However, total
numbers of bacteria in subgingival bioﬁlm of test groups of bothmodels
were not signiﬁcantly different compared with those of untreated con-
trol. A probable explanation for this may be that the concentration of
SAE used in the present study does not reach minimum bactericidal
concentration towards other bacteria in subgingival bioﬁlm. These
ﬁndings indicated an advantage of using SAE for periodontal disease
treatment since it can reduce the number of periodontal pathogensn. The presented percentages of inhibition were calculated from the formula [1− (OD595
nd lower box margins represent 75th percentile and 25th percentile, respectively. The hor-
Fig. 2. Effects of Streblus asper leaf extract (SAE) on cell numbers of P. gingivalis (A),
A. actinomycetemcomitans (B) and total bacteria (C) in subgingival bioﬁlm of tested and
untreated control groups.
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er, further in vivo (clinical) testswill be necessary to determinewhether
the results in vivowill be validated.
Ideally, supragingival and subgingival plaque control should prevent
periodontal tissue inﬂammation and breakdown. However, since
complete plaque removal is unrealistic, prevention may be achieved
by (1) reducing the quantity of plaque below the individual's threshold
for disease or (2) changing the quality of plaque to amore tissue friend-
ly composition (Kornman, 1986). In the present study, we found that
SAE possessed in vitro activity in inhibiting bioﬁlm formation.Moreover,
qualitative changes of plaque may have occurred since a lower number
of A. actinomycetemcomitans and P. gingivalis in subgingival bioﬁlm was
found in tested groups compared with those of untreated control.
Therefore, it would be possible to use SAE for periodontal disease treat-
ment as a subgingival irrigant or developing SAE as a gel for local appli-
cation at periodontitis sites.The age of the bioﬁlm also affects its susceptibility to SAE as shown
in Table 2. We found that older (4- or 8-day-old) bioﬁlms were more
resistant to SAE than were younger (2-day-old) bioﬁlms. These results
are in accordance with those reported by several other groups of in-
vestigators (Anwar et al., 1992; Amorena et al., 1999; Donlan and
Costerton, 2002; Sedlacek and Walker, 2007).
In conclusion, the results obtained in this study demonstrated that
SAE possesses inhibitory effects on subgingival bioﬁlm formation
and is able to inhibit P. gingivalis and A. actinomycetemcomitans in
subgingival bioﬁlm in vitro. This information, together with our previ-
ous studies which reported that SAE possessed antibacterial activity
towards caries associated bacteria (Taweechaisupapong et al., 2000b),
endodontic pathogens (Taweechaisupapong et al., 2000a) and inter-
feres with the in vitro adherence of Candida to human buccal epithelial
cells and acrylic surface (Taweechaisupapong et al., 2005, 2006b),
indicate the multiple advantages of SAE and suggest a potential for de-
veloping SAE as a natural oral hygiene product against oral infection
in people.
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